Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients

  • Kah Poh Loh
  • Colin McHugh
  • Supriya G. Mohile
  • Karen Mustian
  • Marie Flannery
  • Heidi Klepin
  • Rebecca Schnall
  • Eva Culakova
  • Erika Ramsdale
Geriatric Oncology (AR MacKenzie, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Geriatric Oncology

Abstract

Purpose of Review

Older adults with cancer have complex medical needs and often experience higher rates of treatment-related toxicities compared to their younger counterparts. The advent of health information technologies can address multiple gaps in the care of this population. We review the role of existing and emerging technologies in facilitating the use of comprehensive geriatric assessment (CGA) in routine clinics, promoting symptom reporting, and monitoring medication adherence.

Recent Findings

Increasingly, studies demonstrate the feasibility of implementing electronic CGA in routine oncology practices. Evidence also suggests that electronic symptom reporting can improve outcomes in patients with cancer. In addition, technology devices can be used to promote adherence to cancer therapy.

Summary

There are many opportunities for information technology to be integrated into the management and treatment of older adults with cancer. However, further evaluation of these technologies is needed to ensure that they meet the needs of the targeted end users.

Keywords

Information technology Symptom monitoring Medication adherence Geriatric assessment 

Notes

Compliance with Ethical Standards

Conflict of Interest

Kah Poh Loh, Colin McHugh, Supriya G. Mohile, Karen Mustian, Marie Flannery, Heidi Klepin, Rebecca Schnall, Eva Culakova, and Erika Ramsdale declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–56.Google Scholar
  2. 2.
    Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:3457–65.CrossRefGoogle Scholar
  3. 3.
    Mandilaras V, Wan-Chow-Wah D, Monette J, Gaba F, Monette M, Alfonso L. The impact of cancer therapy on cognition in the elderly. Front Pharmacol. 2013;4:48.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol. 2003;1(4 Suppl 2):18–24.PubMedGoogle Scholar
  5. 5.
    Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, et al. Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol. 2016;7(4):270–80.  https://doi.org/10.1016/j.jgo.2016.04.008.
  6. 6.
    Karuturi M, Wong ML, Hsu T, Kimmick GG, Lichtman SM, Holmes HM, et al. Understanding cognition in older patients with cancer. J Geriatr Oncol. 2016;7(4):258–69.  https://doi.org/10.1016/j.jgo.2016.04.004.
  7. 7.
    Herrera AP, Snipes SA, King DW, Torres-Vigil I, Goldberg DS, Weinberg AD. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010;100(S1):S105–12.  https://doi.org/10.2105/AJPH.2009.162982.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NML, Capucine B, et al. What every oncologist should know about geriatric assessment for older patients with cancer: Young SIOG position paper. J Oncol Pract. 2018. (in press).Google Scholar
  9. 9.
    Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005.  https://doi.org/10.1002/cncr.21422.
  10. 10.
    Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118:3377–86.CrossRefPubMedGoogle Scholar
  11. 11.
    Brody EM, Kleban MH. Physical and mental health symptoms of older people: who do they tell? J Am Geriatr Soc. 1981;29(10):442–9.  https://doi.org/10.1111/j.1532-5415.1981.tb01746.x.CrossRefPubMedGoogle Scholar
  12. 12.
    Broderick JE, Schwartz JE, Vikingstad G, Pribbernow M, Grossman S, Stone AA. The accuracy of pain and fatigue items across different reporting periods. Pain. 2008;139(1):146–57.  https://doi.org/10.1016/j.pain.2008.03.024.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bender CM, Gentry AL, Brufsky AM, Casillo FE, Cohen SM, Dailey MM, et al. Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncol Nurs Forum. 2014;41(3):274–85.  https://doi.org/10.1188/14.ONF.274-285.
  14. 14.
    Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–52.CrossRefPubMedGoogle Scholar
  15. 15.
    The National Comprehensive Cancer Network®. 2015. Older adult oncology: NCCN guidelines. [ONLINE] Available at: http://www.nccn.org/professionals/physician_gls/pdf/senior.pdf. [Accessed 09 January 16].
  16. 16.
    Pew Research Center. Americans’ Internet AccessL 2000-2015. 2015 June. Available at: http://www.pewinternet.org/2015/06/26/americans-internet-access-2000-2015/.
  17. 17.
    • Levine DM, Lipsitz SR, Linder JA. Trends in seniors’ use of digital health technology in the United States 2011-2014. JAMA. 2016;316:538–40. Increasing older adult use of technologies for healthcare purposes. CrossRefPubMedGoogle Scholar
  18. 18.
    Clauser SB, Wagner EH, Bowles EJA, Tuzzio L, Greene SM. Improving modern cancer care through information technology. Am J Prev Med. 2011;40(5):S198–207.  https://doi.org/10.1016/j.amepre.2011.01.014.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Zhou C, Crawford A, Serhal E, Kurdyak P, Sockalingam S. The impact of project ECHO on participant and patient outcomes: a systematic review. Acad Med J Assoc Am Med Coll. 2016;91:1439–61.CrossRefGoogle Scholar
  20. 20.
    Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 191–205.Google Scholar
  21. 21.
    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.  https://doi.org/10.1097/00000421-198212000-00014.
  22. 22.
    Puts MTE, Monette J, Girre V, Pepe C, Monette M, Assouline S, et al. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol. 2011;78(2):138–49.  https://doi.org/10.1016/j.critrevonc.2010.04.003.
  23. 23.
    PACE participants, Audisio RA, Pope D, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156–63.CrossRefGoogle Scholar
  24. 24.
    Kothari A, Phillips S, Bretl T, Block K, Weigel T. Components of geriatric assessments predict thoracic surgery outcomes. J Surg Res. 2011;166:5–13.CrossRefPubMedGoogle Scholar
  25. 25.
    Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica. 2007;92:1596–8.CrossRefPubMedGoogle Scholar
  26. 26.
    • Elliot K, Tooze JA, Geller R, Powell BL, Pardee TS, Ritchie E, et al. The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML). Leuk Res. 2014;38:1184–90. Polypharmacy is common and associated with higher mortality in older patients with AML. Google Scholar
  27. 27.
    Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797–810.  https://doi.org/10.1017/S0033291709992285.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Soubeyran P, Bellera C, Goyard J, Heitz D, Curé H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One. 2014;9(12):e115060.  https://doi.org/10.1371/journal.pone.0115060.
  29. 29.
    Ferrat E, Paillaud E, Caillet P, et al. Performance of four frailty classifications in older patients with cancer: prospective elderly cancer patients cohort study. J Clin Oncol. 2017;35:766–77.CrossRefPubMedGoogle Scholar
  30. 30.
    Feng MA, McMillan DT, Crowell K, Muss H, Nielsen ME, Smith AB. Geriatric assessment in surgical oncology: a systematic review. J Surg Res. 2015;193(1):265–72.  https://doi.org/10.1016/j.jss.2014.07.004.CrossRefPubMedGoogle Scholar
  31. 31.
    Neuman HB, Weiss JM, Leverson G, O’Connor ES, Greenblatt DY, LoConte NK, et al. Predictors of short-term post-operative survival after elective colectomy in colon cancer patients ≥80 years of age. Ann Surg Oncol. 2013;20(5):1427–35.  https://doi.org/10.1245/s10434-012-2721-8.
  32. 32.
    Courtney-Brooks M, Tellawi AR, Scalici J, Duska LR, Jazaeri AA, Modesitt SC, et al. Frailty: an outcome predictor for elderly gynecologic oncology patients. Gynecol Oncol. 2012;126(1):20–4.  https://doi.org/10.1016/j.ygyno.2012.04.019.
  33. 33.
    • Loh KP, Magnuson A, Dale W, et al. Association of patient age, function and cognition with cancer treatment decisions: a University of Rochester NCORP study. J Clin Oncol. 2016;34.  https://doi.org/10.1200/JCO.2016.34.15_suppl.10038. Low percentage of community oncologists utilized a geriatric assessment in routine practice.
  34. 34.
    Mohile S, Magnuson S, Pandya C, Velarde C, Duberstein P, Hurria A, et al. Community Oncologists’ Decision-Making For Treatment of Older Patients with Cancer. J Natl Compr Canc Netw. 2018. (in press).Google Scholar
  35. 35.
    Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011;29(10):1290–6.  https://doi.org/10.1200/JCO.2010.30.6985.
  36. 36.
    •• Hurria A, Akiba C, Kim J, et al. Reliability, validity, and feasibility of a computer-based geriatric assessment for older adults with cancer. J Oncol Pract. 2016;12:e1025–34. Computer-based geriatric assessment is feasible in the geriatric oncology population. CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    • Bhatt G, Hofmeister CC, Efebera YA, et al. A feasibility study of electronic geriatric assessment for real-time morbidity evaluation. J Clin Oncol. 2016;34.  https://doi.org/10.1200/JCO.2016.34.15_suppl.e21523. Electronic geriatric assessment is feasible in patients with hematologic malignancies.
  38. 38.
    • McCleary NJ, Wigler D, Berry D, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18:64–72. Computer-based geriatric assessment is feasible in patients with gastrointestinal cancer, but half required resistance completing the assessment. CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    •• Shahrokni A, Tin A, Downey RJ, Strong V, Mahmoudzadeh S, Boparai MK, et al. Electronic rapid fitness assessment: a novel tool for preoperative evaluation of the geriatric oncology patient. J Natl Compr Cancer Netw. 2017;15:172–9. Electronic geriatric assessment integrated with the electronic medical record is feasible. Google Scholar
  40. 40.
    Nathwani N, Mohile SG, Lipe B, Carig K, DiGiovanni L, Davis A, et al. Integrating a touchscreen-based brief geriatric assessment in older adults with multiple myeloma. J Clin Oncol. 2017;35:e21703–3.Google Scholar
  41. 41.
    Horgan AM, Seruga B, Pond GR, Alibhai SM, Amir E, De Wit R, et al. Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial. J Geriatr Oncol. 2014;5(2):119–26.  https://doi.org/10.1016/j.jgo.2013.12.001.
  42. 42.
    Muss HB, Berry DA, Cirrincione C, Budman DR, Henderson IC, Citron ML, et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer And Leukemia Group B experience. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25:3699–704.Google Scholar
  43. 43.
    • Stinchcombe TE, Zhang Y, Vokes EE, et al. Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute cooperative group studies. J Clin Oncol Off J Am Soc Clin Oncol. 2017;  https://doi.org/10.1200/JCO.2016.71.4758. Older adults with cancer derived benefits from treatment but experienced increased toxicity.
  44. 44.
    Quoix E, Zalcman G, Oster J-P, Westeel V, Pichon E, Lavolé A, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet Lond Engl. 2011;378(9796):1079–88.  https://doi.org/10.1016/S0140-6736(11)60780-0.
  45. 45.
    Cataldo JK, Paul S, Cooper B, et al. Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer. 2013;13:6.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119(2):121–6.  https://doi.org/10.7326/0003-4819-119-2-199307150-00005.CrossRefGoogle Scholar
  47. 47.
    Jensen RE, Snyder CF, Abernethy AP, Basch E, Potosky AL, Roberts AC, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014;10:e215–e222.Google Scholar
  48. 48.
    •• Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2015;  https://doi.org/10.1200/JCO.2015.63.0830. Electronic symptom monitoring improved health-related quality of life, reduced emergency room visits, and reduced hospitalizations.
  49. 49.
    •• Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;  https://doi.org/10.1001/jama.2017.7156. Electronic symptom monitoring improved overall survival.
  50. 50.
    Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2009;17:437–44.Google Scholar
  51. 51.
    McCann L, Maguire R, Miller M, Kearney N. Patients’ perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity. Eur J Cancer Care (Engl). 2009;18(2):156–64.  https://doi.org/10.1111/j.1365-2354.2008.00938.x.CrossRefGoogle Scholar
  52. 52.
    Maguire R, Fox PA, McCann L, Miaskowski C, Kotronoulas G, Miller M, et al. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer. BMJ Open. 2017;7(5):e015016.  https://doi.org/10.1136/bmjopen-2016-015016.
  53. 53.
    Increased use of oral chemotherapy drugs spurs increased attention to patient compliance. J Oncol Pract. 2008;4:175–7.  https://doi.org/10.1200/JOP.0843002.
  54. 54.
    Ziller V, Kalder M, Albert U-S, Holzhauer W, Ziller M, Wagner U, et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2009;20:431–6.Google Scholar
  55. 55.
    Greer JA, Amoyal N, Nisotel L, Fishbein JN, MacDonald J, Stagl J, et al. A systematic review of adherence to oral antineoplastic therapies. Oncologist. 2016;21(3):354–76.  https://doi.org/10.1634/theoncologist.2015-0405.
  56. 56.
    •• Puts MTE, Tapscott B, Fitch M, Howell D, Monette J, Wan-Chow-Wah D, et al. A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment. Cancer Treat Rev. 2015;41:197–215. Adherence rates to cancer treatment vary across patients. Google Scholar
  57. 57.
    Stilley CS, Bender CM, Dunbar-Jacob J, Sereika S, Ryan CM. The impact of cognitive function on medication management: three studies. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2010;29:50–5.Google Scholar
  58. 58.
    • Loh KP, Pandya C, Zittel J, et al. Associations of sleep disturbance with physical function and cognition in older adults with cancer. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2017;  https://doi.org/10.1007/s00520-017-3724-6. Almost 50% of patients referred to a geriatric oncology were screened positive for cognitive impairment.
  59. 59.
    Bennett JA, Cameron LD, Whitehead LC, Porter D. Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine. J Gen Intern Med. 2009;24(10):1089–94.  https://doi.org/10.1007/s11606-009-0979-8.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Fitzpatrick AL, Powe NR, Cooper LS, Ives DG, Robbins JA. Barriers to health care access among the elderly and who perceives them. Am J Public Health. 2004;94(10):1788–94.  https://doi.org/10.2105/AJPH.94.10.1788.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Maggiore RJ, Gross CP, Hurria A. Polypharmacy in older adults with cancer. Oncologist. 2010;15(5):507–22.  https://doi.org/10.1634/theoncologist.2009-0290.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7(1):11–22.  https://doi.org/10.1177/2042098615615472.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Marcum ZA, Gellad WF. Medication adherence to multi-drug regimens. Clin Geriatr Med. 2012;28(2):287–300.  https://doi.org/10.1016/j.cger.2012.01.008.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM. Polypharmacy and potentially inappropriate medication use in geriatric oncology. J Geriatr Oncol. 2016;7(5):346–53.  https://doi.org/10.1016/j.jgo.2016.07.010.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    • Neugut AI, Zhong X, Wright JD, Accordino M, Yang J, Hershman DL. Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncol. 2016;2:1326–32. Nonadherence to chronic medications was associated with nonadherence to oral hormonal therapy. CrossRefPubMedGoogle Scholar
  66. 66.
    DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811.  https://doi.org/10.1097/00005650-200209000-00009.CrossRefPubMedGoogle Scholar
  67. 67.
    Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(9):1053–9.  https://doi.org/10.1200/JCO.2014.58.3062.CrossRefGoogle Scholar
  68. 68.
    Spoelstra SL, Given CW. Assessment and measurement of adherence to oral antineoplastic agents. Semin Oncol Nurs. 2011;27(2):116–32.  https://doi.org/10.1016/j.soncn.2011.02.004.CrossRefPubMedGoogle Scholar
  69. 69.
    •• Burhenn PS, Smudde J. Using tools and technology to promote education and adherence to oral agents for cancer. Clin J Oncol Nurs. 2015;19:53–9. A literature search on the tools and technology for promoting adherence to oral cancer treatments. CrossRefPubMedGoogle Scholar
  70. 70.
    •• Mislang AR, Wildes TM, Kanesvaran R, Baldini C, Holmes HM, Nightingale G, et al. Adherence to oral cancer therapy in older adults: the International Society of Geriatric Oncology (SIOG) taskforce recommendations. Cancer Treat Rev. 2017;57:58–66. Recommendations from SIOG on adherence to oral cancer treatment. Google Scholar
  71. 71.
    de Figueiredo Junior AG, Forones NM. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer. Arq Gastroenterol. 2014;51:186–91.CrossRefPubMedGoogle Scholar
  72. 72.
    Talati C, Ontiveros EP, Griffiths EA, Wang ES, Wetzler M. How we will treat chronic myeloid leukemia in 2016. Blood Rev. 2015;29(2):137–42.  https://doi.org/10.1016/j.blre.2014.12.003.CrossRefPubMedGoogle Scholar
  73. 73.
    Vitality - NantHealth. https://nanthealth.com/vitality/. Accessed 7 Sep 2017.
  74. 74.
    Improving medication adherence for oncology patients through high-tech interventions. In: Spec. Pharm. Times. https://www.specialtypharmacytimes.com/publications/specialty-pharmacy-times/2015/june-2015/improving-medication-adherence-for-oncology-patients-through-high-tech-interventions. Accessed 7 Sep 2017.
  75. 75.
    Rogers WA, Fisk AD. Toward a psychological science of advanced technology design for older adults. J Gerontol B Psychol Sci Soc Sci. 2010;65B(6):645–53.  https://doi.org/10.1093/geronb/gbq065.CrossRefPubMedCentralGoogle Scholar
  76. 76.
    • Evans J, Papadopoulos A, Silvers CT, Charness N, Boot WR, Schlachta-Fairchild L, et al. Remote health monitoring for older adults and those with heart failure: adherence and system usability. Telemed J E Health. 2016;22:480–8. A number of issues specific to older adults were identified when studying technology use in this population. Google Scholar
  77. 77.
    • Chaudhuri S, Thompson H, Demiris G. Fall detection devices and their use with older adults: a systematic review. J Geriatr Phys Ther. 2014;37:178–96. Challenges encountered when studying technology use in older adults. CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Charness N, Boot WR. Aging and information technology use potential and barriers. Curr Dir Psychol Sci. 2009;18(5):253–8.  https://doi.org/10.1111/j.1467-8721.2009.01647.x.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Kah Poh Loh
    • 1
  • Colin McHugh
    • 1
  • Supriya G. Mohile
    • 1
  • Karen Mustian
    • 1
  • Marie Flannery
    • 1
  • Heidi Klepin
    • 2
  • Rebecca Schnall
    • 3
  • Eva Culakova
    • 1
  • Erika Ramsdale
    • 1
  1. 1.James P Wilmot Cancer InstituteUniversity of Rochester School of Medicine and DentistryRochesterUSA
  2. 2.Wake Forest Baptist HealthWinston-SalemUSA
  3. 3.Columbia University School of NursingNew YorkUSA

Personalised recommendations